These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10081620

  • 1. Effects of cicletanine on the progression of renal failure in 5/6 nephrectomized hypertensive rats.
    Nakamoto H, Suzuki H, Ohishi A, Katsumata H, Sakaguchi H, Saruta T.
    Clin Exp Pharmacol Physiol; 1999 Mar; 26(3):236-41. PubMed ID: 10081620
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of cicletanine on hypertension-induced decreases in the renal kallikrein-kinin and prostaglandin systems in stroke-prone spontaneously hypertensive rats.
    Emond C, Bompart G, Rakotoarivony J, Bascands JL, Pecher C, Adam A, Tarrade T, Berthet P, Girolami JP.
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):601-8. PubMed ID: 1280717
    [Abstract] [Full Text] [Related]

  • 3. Effects of antihypertensive agents on blood pressure and the progress of renal failure in partially nephrectomized spontaneously hypertensive rats.
    Katsumata H, Suzuki H, Ohishi A, Nakamoto H, Saruta T, Sakaguchi H.
    Lab Invest; 1990 Apr; 62(4):474-80. PubMed ID: 2185377
    [Abstract] [Full Text] [Related]

  • 4. Protective effect of cicletanine on renal function in diabetic spontaneously hypertensive rats.
    Duran MJ, Sennoune S, Arnaud C, Garcia S, Droy-Lefaix MT, Maixent JM.
    Cell Mol Biol (Noisy-le-grand); 2004 Nov; 50(7):869-74. PubMed ID: 15672472
    [Abstract] [Full Text] [Related]

  • 5. Effects of cicletanine on prostaglandin I2 and E2 levels in patients with essential hypertension.
    Yasu T, Imanishi M.
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):750-5. PubMed ID: 9234829
    [Abstract] [Full Text] [Related]

  • 6. Renal hemodynamics and sodium excretion after acute and chronic administration of cicletanine in normotensive and hypertensive subjects.
    Moulin B, Fillastre JP, Godin M, Coquerel A, Decoopman E.
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):292-9. PubMed ID: 7752655
    [Abstract] [Full Text] [Related]

  • 7. Renal-protective effect of nondepressor dose of cicletanine in diabetic rats with hypertension.
    Kohzuki M, Wu XM, Kamimoto M, Yoshida K, Nagasaka M, Kanazawa M, Yasujima M, Saito T, Sato T.
    Am J Hypertens; 2000 Mar; 13(3):298-306. PubMed ID: 10777035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Involvement of the sympathetic nervous system in antihypertensive effect of cicletanine in salt-loaded young spontaneously hypertensive rats.
    Ando K, Ono A, Sato Y, Asano S, Fujita T.
    Am J Hypertens; 1994 Jun; 7(6):550-4. PubMed ID: 7917154
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipid metabolism and renal protection by chronic cicletanine treatment in Dahl salt-sensitive rats with salt-induced hypertension.
    Uehara Y, Hirawa N, Kawabata Y, Akie Y, Ichikawa A, Funahashi N, Goto A, Omata M.
    Blood Press; 1997 May; 6(3):180-7. PubMed ID: 9181257
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
    Quest DW, Wilson TW.
    Jpn J Pharmacol; 1998 Dec; 78(4):479-86. PubMed ID: 9920205
    [Abstract] [Full Text] [Related]

  • 17. Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high-salt diet.
    Kanno Y, Suzuki H, Okada H, Saruta T.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):480-4. PubMed ID: 7515994
    [Abstract] [Full Text] [Related]

  • 18. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV, Talan MI, Agalakova NI, Droy-Lefaix MT, Lakatta EG, Bagrov AY.
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [Abstract] [Full Text] [Related]

  • 19. Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids.
    Ferry N, Geoffroy J, Pozet N, Cuisinaud G, Benzoni D, Zech PY, Sassard J.
    Br J Clin Pharmacol; 1988 Mar; 25(3):359-66. PubMed ID: 3358898
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.